Efforts to make a prophylactic HIV vaccine have identified monoclonal antibodies that potently suppress viral replication. Studies in monkeys show that these reagents effectively treat HIV infection. See Article p.224 & Letter p.277
This is a preview of subscription content, access via your institution
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Rent or buy this article
Prices vary by article type
Prices may be subject to local taxes which are calculated during checkout
Mascola, J. R. & Haynes, B. F. Immunol. Rev. 254, 225–244 (2013).
Klein, F. et al. Science 341, 1199–1204 (2013).
Barouch, D. H. et al. Nature 503, 224–228 (2013).
Shingai, M. et al. Nature 503, 277–280 (2013).
Moldt, B. et al. Proc. Natl Acad. Sci. USA 109, 18921–18925 (2012).
Volberding, P. A. & Deeks, S. G. Lancet 376, 49–62 (2010).
Palmer, S. et al. Proc. Natl Acad. Sci. USA 105, 3879–3884 (2008).
Deeks, S. G. et al. Nature Rev. Immunol. 12, 607–614 (2012).
Deeks, S., Drosten, C., Picker, L., Subbarao, K. & Suzich, J. Nature Med. 19, 30–34 (2013).
Richman, D. D. et al. Science 323, 1304–1307 (2009).
About this article
Cite this article
Picker, L., Deeks, S. Antibodies advance the search for a cure. Nature 503, 207–208 (2013). https://doi.org/10.1038/nature12703